{
 "drug": "Methylprednisolone Acetate Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "12/15/2021",
 "dayN": 1714,
 "cat": "Rheumatology",
 "companies": [
  "Sagent Pharmaceuticals",
  "Amneal Pharmaceuticals",
  "Pfizer Inc.",
  "Eugia US LLC",
  "Par Health, USA LLC"
 ],
 "reasons": [
  "Shortage of an active ingredient",
  "Demand increase for the drug",
  "Other"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "25021-820-10",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "866-625-1618",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: November 2026",
   "openfda": {
    "application_number": [
     "ANDA201835"
    ],
    "brand_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Sagent Pharmaceuticals"
    ],
    "product_ndc": [
     "25021-820",
     "25021-821"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1358610",
     "1358617"
    ],
    "spl_id": [
     "f73618f0-0723-4d8b-8a8d-b9081acb44f9"
    ],
    "spl_set_id": [
     "f98314ea-a4e4-4f78-987b-3e9b45a08bb4"
    ],
    "package_ndc": [
     "25021-820-05",
     "25021-820-10",
     "25021-821-05"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10)",
   "company_name": "Sagent Pharmaceuticals",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "25021-820-05",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "866-625-1618",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: November 2026",
   "openfda": {
    "application_number": [
     "ANDA201835"
    ],
    "brand_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Sagent Pharmaceuticals"
    ],
    "product_ndc": [
     "25021-820",
     "25021-821"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1358610",
     "1358617"
    ],
    "spl_id": [
     "f73618f0-0723-4d8b-8a8d-b9081acb44f9"
    ],
    "spl_set_id": [
     "f98314ea-a4e4-4f78-987b-3e9b45a08bb4"
    ],
    "package_ndc": [
     "25021-820-05",
     "25021-820-10",
     "25021-821-05"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05)",
   "company_name": "Sagent Pharmaceuticals",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "70121-1573-5",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "866-525-7270",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA210043"
    ],
    "brand_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "70121-1573",
     "70121-1574"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1743779",
     "1743855"
    ],
    "spl_id": [
     "af4215ff-94ca-44f8-8506-3024e738cd13"
    ],
    "spl_set_id": [
     "d944240d-2c19-46ba-ad4f-3fbee7b8629c"
    ],
    "package_ndc": [
     "70121-1573-1",
     "70121-1573-5",
     "70121-1574-1",
     "70121-1574-5"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "06/17/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-5)",
   "company_name": "Amneal Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "70121-1574-5",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "866-525-7270",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA210043"
    ],
    "brand_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "70121-1574",
     "70121-1573"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1743779",
     "1743855"
    ],
    "spl_id": [
     "af4215ff-94ca-44f8-8506-3024e738cd13"
    ],
    "spl_set_id": [
     "d944240d-2c19-46ba-ad4f-3fbee7b8629c"
    ],
    "package_ndc": [
     "70121-1573-1",
     "70121-1573-5",
     "70121-1574-1",
     "70121-1574-5"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "06/17/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5)",
   "company_name": "Amneal Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-3073-22",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery: September 2026; Estimated Recovery: December 2026",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-3073",
     "0009-3475"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE",
     "INTRA-ARTICULAR"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1743779",
     "1743781",
     "1743855",
     "1743856"
    ],
    "spl_id": [
     "e4917f75-3e1c-4f3c-803d-d9ec65df06c7",
     "742fcec7-8db3-4cc6-b276-42587a993810"
    ],
    "spl_set_id": [
     "bf1b104d-85cb-414d-a366-78068c82c883",
     "9a7b3837-e038-48bf-97e9-78ad463760dc"
    ],
    "package_ndc": [
     "0009-3073-22",
     "0009-3073-23",
     "0009-3475-22",
     "0009-3475-23",
     "0009-3073-01",
     "0009-3073-03",
     "0009-3475-01",
     "0009-3475-03"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-0274-01",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0274",
     "0009-0280",
     "0009-0306"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1358510",
     "1358512",
     "1358610",
     "1358612",
     "1358617",
     "1358619"
    ],
    "spl_id": [
     "267dd735-f800-4735-ba1c-d39d00f0cee5"
    ],
    "spl_set_id": [
     "823b0010-2b57-4e76-b5ac-4a8c2963438f"
    ],
    "package_ndc": [
     "0009-0274-01",
     "0009-0280-02",
     "0009-0280-51",
     "0009-0280-03",
     "0009-0280-52",
     "0009-0306-02",
     "0009-0306-12"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01)",
   "company_name": "Pfizer Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-3475-01",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Limited Availability",
   "related_info": "Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-3475",
     "0009-3073"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1743779",
     "1743781",
     "1743855",
     "1743856"
    ],
    "spl_id": [
     "742fcec7-8db3-4cc6-b276-42587a993810"
    ],
    "spl_set_id": [
     "9a7b3837-e038-48bf-97e9-78ad463760dc"
    ],
    "package_ndc": [
     "0009-3073-01",
     "0009-3073-03",
     "0009-3475-01",
     "0009-3475-03"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "55150-313-01",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "888-238-7880",
   "availability": "Unavailable",
   "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA211930"
    ],
    "brand_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Eugia US LLC"
    ],
    "product_ndc": [
     "55150-313",
     "55150-314"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1358610",
     "1358617"
    ],
    "spl_id": [
     "25c5133c-ee17-4be0-88a3-d0231e38f5a0"
    ],
    "spl_set_id": [
     "a0cbcdb5-f657-49f7-8f86-cc5959d69db0"
    ],
    "package_ndc": [
     "55150-313-25",
     "55150-313-01",
     "55150-314-25",
     "55150-314-01"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/06/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01)",
   "company_name": "Eugia US LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "06/16/2022",
   "package_ndc": "42023-240-01",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "800-828-9393",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)",
   "company_name": "Par Health, USA LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-0280-02",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0280",
     "0009-0274",
     "0009-0306"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1358510",
     "1358512",
     "1358610",
     "1358612",
     "1358617",
     "1358619"
    ],
    "spl_id": [
     "267dd735-f800-4735-ba1c-d39d00f0cee5"
    ],
    "spl_set_id": [
     "823b0010-2b57-4e76-b5ac-4a8c2963438f"
    ],
    "package_ndc": [
     "0009-0274-01",
     "0009-0280-02",
     "0009-0280-51",
     "0009-0280-03",
     "0009-0280-52",
     "0009-0306-02",
     "0009-0306-12"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)",
   "company_name": "Pfizer Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-0280-51",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0280",
     "0009-0274",
     "0009-0306"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1358510",
     "1358512",
     "1358610",
     "1358612",
     "1358617",
     "1358619"
    ],
    "spl_id": [
     "267dd735-f800-4735-ba1c-d39d00f0cee5"
    ],
    "spl_set_id": [
     "823b0010-2b57-4e76-b5ac-4a8c2963438f"
    ],
    "package_ndc": [
     "0009-0274-01",
     "0009-0280-02",
     "0009-0280-51",
     "0009-0280-03",
     "0009-0280-52",
     "0009-0306-02",
     "0009-0306-12"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51)",
   "company_name": "Pfizer Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-3073-03",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Limited Availability",
   "related_info": "Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-3073",
     "0009-3475"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE",
     "INTRA-ARTICULAR"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1743779",
     "1743781",
     "1743855",
     "1743856"
    ],
    "spl_id": [
     "e4917f75-3e1c-4f3c-803d-d9ec65df06c7",
     "742fcec7-8db3-4cc6-b276-42587a993810"
    ],
    "spl_set_id": [
     "bf1b104d-85cb-414d-a366-78068c82c883",
     "9a7b3837-e038-48bf-97e9-78ad463760dc"
    ],
    "package_ndc": [
     "0009-3073-22",
     "0009-3073-23",
     "0009-3475-22",
     "0009-3475-23",
     "0009-3073-01",
     "0009-3073-03",
     "0009-3475-01",
     "0009-3475-03"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "70121-1573-1",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "866-525-7270",
   "availability": "Limited Availability",
   "related_info": "On backorder. Estimated recovery: late July",
   "openfda": {
    "application_number": [
     "ANDA210043"
    ],
    "brand_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "70121-1573",
     "70121-1574"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1743779",
     "1743855"
    ],
    "spl_id": [
     "af4215ff-94ca-44f8-8506-3024e738cd13"
    ],
    "spl_set_id": [
     "d944240d-2c19-46ba-ad4f-3fbee7b8629c"
    ],
    "package_ndc": [
     "70121-1573-1",
     "70121-1573-5",
     "70121-1574-1",
     "70121-1574-5"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "06/17/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1)",
   "company_name": "Amneal Pharmaceuticals",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-3073-23",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Limited Availability",
   "related_info": "Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-3073",
     "0009-3475"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE",
     "INTRA-ARTICULAR"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1743779",
     "1743781",
     "1743855",
     "1743856"
    ],
    "spl_id": [
     "e4917f75-3e1c-4f3c-803d-d9ec65df06c7",
     "742fcec7-8db3-4cc6-b276-42587a993810"
    ],
    "spl_set_id": [
     "bf1b104d-85cb-414d-a366-78068c82c883",
     "9a7b3837-e038-48bf-97e9-78ad463760dc"
    ],
    "package_ndc": [
     "0009-3073-22",
     "0009-3073-23",
     "0009-3475-22",
     "0009-3475-23",
     "0009-3073-01",
     "0009-3073-03",
     "0009-3475-01",
     "0009-3475-03"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-0306-02",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0306",
     "0009-0274",
     "0009-0280"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1358510",
     "1358512",
     "1358610",
     "1358612",
     "1358617",
     "1358619"
    ],
    "spl_id": [
     "267dd735-f800-4735-ba1c-d39d00f0cee5"
    ],
    "spl_set_id": [
     "823b0010-2b57-4e76-b5ac-4a8c2963438f"
    ],
    "package_ndc": [
     "0009-0274-01",
     "0009-0280-02",
     "0009-0280-51",
     "0009-0280-03",
     "0009-0280-52",
     "0009-0306-02",
     "0009-0306-12"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02)",
   "company_name": "Pfizer Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "70121-1574-1",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "866-525-7270",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA210043"
    ],
    "brand_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Amneal Pharmaceuticals LLC"
    ],
    "product_ndc": [
     "70121-1574",
     "70121-1573"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1743779",
     "1743855"
    ],
    "spl_id": [
     "af4215ff-94ca-44f8-8506-3024e738cd13"
    ],
    "spl_set_id": [
     "d944240d-2c19-46ba-ad4f-3fbee7b8629c"
    ],
    "package_ndc": [
     "70121-1573-1",
     "70121-1573-5",
     "70121-1574-1",
     "70121-1574-5"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "06/17/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-1)",
   "company_name": "Amneal Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-3475-03",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-3475",
     "0009-3073"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1743779",
     "1743781",
     "1743855",
     "1743856"
    ],
    "spl_id": [
     "742fcec7-8db3-4cc6-b276-42587a993810"
    ],
    "spl_set_id": [
     "9a7b3837-e038-48bf-97e9-78ad463760dc"
    ],
    "package_ndc": [
     "0009-3073-01",
     "0009-3073-03",
     "0009-3475-01",
     "0009-3475-03"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03)",
   "company_name": "Pfizer Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-0280-03",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Limited Availability",
   "related_info": "Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0280",
     "0009-0274",
     "0009-0306"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1358510",
     "1358512",
     "1358610",
     "1358612",
     "1358617",
     "1358619"
    ],
    "spl_id": [
     "267dd735-f800-4735-ba1c-d39d00f0cee5"
    ],
    "spl_set_id": [
     "823b0010-2b57-4e76-b5ac-4a8c2963438f"
    ],
    "package_ndc": [
     "0009-0274-01",
     "0009-0280-02",
     "0009-0280-51",
     "0009-0280-03",
     "0009-0280-52",
     "0009-0306-02",
     "0009-0306-12"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-0280-52",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0280",
     "0009-0274",
     "0009-0306"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1358510",
     "1358512",
     "1358610",
     "1358612",
     "1358617",
     "1358619"
    ],
    "spl_id": [
     "267dd735-f800-4735-ba1c-d39d00f0cee5"
    ],
    "spl_set_id": [
     "823b0010-2b57-4e76-b5ac-4a8c2963438f"
    ],
    "package_ndc": [
     "0009-0274-01",
     "0009-0280-02",
     "0009-0280-51",
     "0009-0280-03",
     "0009-0280-52",
     "0009-0306-02",
     "0009-0306-12"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52)",
   "company_name": "Pfizer Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-3073-01",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Limited Availability",
   "related_info": "Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-3073",
     "0009-3475"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE",
     "INTRA-ARTICULAR"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1743779",
     "1743781",
     "1743855",
     "1743856"
    ],
    "spl_id": [
     "e4917f75-3e1c-4f3c-803d-d9ec65df06c7",
     "742fcec7-8db3-4cc6-b276-42587a993810"
    ],
    "spl_set_id": [
     "bf1b104d-85cb-414d-a366-78068c82c883",
     "9a7b3837-e038-48bf-97e9-78ad463760dc"
    ],
    "package_ndc": [
     "0009-3073-22",
     "0009-3073-23",
     "0009-3475-22",
     "0009-3475-23",
     "0009-3073-01",
     "0009-3073-03",
     "0009-3475-01",
     "0009-3475-03"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "0009-0306-12",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA011757"
    ],
    "brand_name": [
     "DEPO-MEDROL"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0306",
     "0009-0274",
     "0009-0280"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1358510",
     "1358512",
     "1358610",
     "1358612",
     "1358617",
     "1358619"
    ],
    "spl_id": [
     "267dd735-f800-4735-ba1c-d39d00f0cee5"
    ],
    "spl_set_id": [
     "823b0010-2b57-4e76-b5ac-4a8c2963438f"
    ],
    "package_ndc": [
     "0009-0274-01",
     "0009-0280-02",
     "0009-0280-51",
     "0009-0280-03",
     "0009-0280-52",
     "0009-0306-02",
     "0009-0306-12"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12)",
   "company_name": "Pfizer Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "25021-821-05",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "866-625-1618",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: November 2026, Product on hand is 8-12 months of dating prior to expiry",
   "openfda": {
    "application_number": [
     "ANDA201835"
    ],
    "brand_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Sagent Pharmaceuticals"
    ],
    "product_ndc": [
     "25021-821",
     "25021-820"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRASYNOVIAL",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1358610",
     "1358617"
    ],
    "spl_id": [
     "f73618f0-0723-4d8b-8a8d-b9081acb44f9"
    ],
    "spl_set_id": [
     "f98314ea-a4e4-4f78-987b-3e9b45a08bb4"
    ],
    "package_ndc": [
     "25021-820-05",
     "25021-820-10",
     "25021-821-05"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05)",
   "company_name": "Sagent Pharmaceuticals",
   "shortage_reason": "Shortage of an active ingredient",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/15/2021",
   "package_ndc": "55150-314-01",
   "generic_name": "Methylprednisolone Acetate Injection",
   "contact_info": "888-238-7880",
   "availability": "Unavailable",
   "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA211930"
    ],
    "brand_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "generic_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "manufacturer_name": [
     "Eugia US LLC"
    ],
    "product_ndc": [
     "55150-314",
     "55150-313"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "METHYLPREDNISOLONE ACETATE"
    ],
    "rxcui": [
     "1358610",
     "1358617"
    ],
    "spl_id": [
     "25c5133c-ee17-4be0-88a3-d0231e38f5a0"
    ],
    "spl_set_id": [
     "a0cbcdb5-f657-49f7-8f86-cc5959d69db0"
    ],
    "package_ndc": [
     "55150-313-25",
     "55150-313-01",
     "55150-314-25",
     "55150-314-01"
    ],
    "unii": [
     "43502P7F0P"
    ]
   },
   "update_date": "08/06/2026",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01)",
   "company_name": "Eugia US LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  }
 ]
}